designing novel protein antibacterials

GangaGen Biotechnologies Private Limited (GBPL), India, is a biologics company specialized in discovering, designing and developing novel therapies for treating serious bacterial infections. Its mission is to transform the global fight against anti-microbial resistance by pioneering discovery and development of novel therapies. GBPL was founded and registered in India in 2000 by Prof J. Ramachandran and became a subsidiary of GangaGen Inc., a Delaware company in the US, in 2001. It advanced a candidate compound into human clinical trials for decolonizati

Read more

clinical trialsdiscovery and development of biologics